S615-0559 Screening compound: 3-{3-[2-(cyclopentylmethoxy)ethyl]-1,2,4-oxadiazol-5-yl}-N-[(4-methylphenyl)methyl]pyrrolidine-1-carboxamide

S615-0559 Screening compound: 3-{3-[2-(cyclopentylmethoxy)ethyl]-1,2,4-oxadiazol-5-yl}-N-[(4-methylphenyl)methyl]pyrrolidine-1-carboxamide
S615-0559 Screening compound: 3-{3-[2-(cyclopentylmethoxy)ethyl]-1,2,4-oxadiazol-5-yl}-N-[(4-methylphenyl)methyl]pyrrolidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S615-0559
3-{3-[2-(cyclopentylmethoxy)ethyl]-1,2,4-oxadiazol-5-yl}-N-[(4-methylphenyl)methyl]pyrrolidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S615-0559

Molecular Formula

C23H32N4O3 (C23 H32 N4 O3)

Compound Name

3-{3-[2-(cyclopentylmethoxy)ethyl]-1,2,4-oxadiazol-5-yl}-N-[(4-methylphenyl)methyl]pyrrolidine-1-carboxamide

IUPAC name

3-{3-[2-(cyclopentylmethoxy)ethyl]-124-oxadiazol-5-yl}-N-[(4-methylphenyl)methyl]pyrrolidine-1-carboxamide

SMILES

Cc1ccc(CNC(N(CC2)CC2c2nc(CCOCC3CCCC3)no2)=O)cc1

InChI

InChI=1S/C23H32N4O3/c1-17-6-8-18(9-7-17)14-24-23(28)27-12-10-20(15-27)22-25-21(26-30-22)11-13-29-16-19-4-2-3-5-19/h6-9,19-20H,2-5,10-16H2,1H3,(H,24,28)/t20-/m1/s1

InChI Key

XNZPFXPSVDFZQS-HXUWFJFHSA-N

MDL Number (MFCD)

MFCD31988652

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

412.53

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.006

Distribution Coefficient, logD

4.006

Water Solubility, LogSw

-3.97

Polar Surface Area

68.636

Acid Dissociation Constant (pKa)

14.42

Base Dissociation Constant (pKb)

-1.85

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

60.87

S615-0559 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S615-0559 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S615-0559?
Check Price and Availability of S615-0559, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S615-0559 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S615-0559
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S615-0559
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S615-0559 available by request